MilliporeSigma
  • Home
  • Search Results
  • Persistent reduction of hippocampal glutamine synthetase expression after status epilepticus in immature rats.

Persistent reduction of hippocampal glutamine synthetase expression after status epilepticus in immature rats.

The European journal of neuroscience (2014-10-29)
W Saskia van der Hel, Ellen V S Hessel, Ineke W M Bos, Sandra D Mulder, Suzanne A M W Verlinde, Pieter van Eijsden, Pierre N E de Graan
ABSTRACT

Mesiotemporal sclerosis (MTS), the most frequent form of drug-resistant temporal lobe epilepsy, often develops after an initial precipitating injury affecting the immature brain. To analyse early processes in epileptogenesis we used the juvenile pilocarpine model to study status epilepticus (SE)-induced changes in expression of key components in the glutamate-glutamine cycle, known to be affected in MTS patients. SE was induced by Li(+) /pilocarpine injection in 21-day-old rats. At 2-19 weeks after SE hippocampal protein expression was analysed by immunohistochemistry and neuron damage by FluoroJade staining. Spontaneous seizures occurred in at least 44% of animals 15-18 weeks after SE. As expected in this model, we did not observe loss of principal hippocampal neurons. Neuron damage was most pronounced in the hilus, where we also detected progressive loss of parvalbumin-positive GABAergic interneurons. Hilar neuron loss (or end-folium sclerosis), a common feature in patients with MTS, was accompanied by a progressively decreased glutamine synthetase (GS)-immunoreactivity from 2 (-15%) to 19 weeks (-33.5%) after SE. Immunoreactivity for excitatory amino-acid transporters, vesicular glutamate transporter 1 and glial fibrillary acidic protein was unaffected. Our data show that SE elicited in 21-day-old rats induces a progressive reduction in hilar GS expression without affecting other key components of the glutamate-glutamine cycle. Reduced expression of glial enzyme GS was first detected 2 weeks after SE, and thus clearly before spontaneous recurrent seizures occurred. These results support the hypothesis that reduced GS expression is an early event in the development of hippocampal sclerosis in MTS patients and emphasize the importance of astrocytes in early epileptogenesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Potassium permanganate, puriss. p.a., ACS reagent, Hg ≤0.000005%, ≥99.0% (RT)
Lithium chloride solution, 2 M in ethanol
Sigma-Aldrich
Potassium permanganate, ≤150 μm particle size, 97%
Sigma-Aldrich
Lithium chloride, ReagentPlus®, 99%
Sigma-Aldrich
Potassium permanganate, ACS reagent, ≥99.0%, low in mercury
Sigma-Aldrich
Potassium permanganate, ACS reagent, ≥99.0%
Sigma-Aldrich
Lithium chloride, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, 99%
Sigma-Aldrich
Lithium chloride, puriss. p.a., anhydrous, ≥99.0% (AT)
Sigma-Aldrich
Lithium chloride, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Lithium chloride, ACS reagent, ≥99%
Sigma-Aldrich
Potassium permanganate, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99%
Sigma-Aldrich
Lithium chloride, BioXtra, ≥99.0% (titration)
Sigma-Aldrich
Lithium chloride solution, 8 M, for molecular biology, ≥99%
Sigma-Aldrich
Lithium chloride, for molecular biology, ≥99%
Sigma-Aldrich
Lithium chloride, BioUltra, for molecular biology, anhydrous, ≥99.0% (AT)
Supelco
Lithium chloride solution, 1 M in ethanol
Sigma-Aldrich
Lithium chloride solution, 0.5 M in anhydrous tetrahydrofuran
Sigma-Aldrich
Lithium-7Li chloride, 99 atom % 7Li, 99% (CP)
Sigma-Aldrich
Lithium chloride, AnhydroBeads, −10 mesh, 99.998% trace metals basis
Sigma-Aldrich
Lithium chloride, AnhydroBeads, −10 mesh, ≥99.9% trace metals basis
Sigma-Aldrich
Lithium chloride, powder, ≥99.98% trace metals basis
Sigma-Aldrich
p-Xylene-bis(N-pyridinium bromide), ≥95% (TLC)
Supelco
o-Xylene, analytical standard
Sigma-Aldrich
o-Xylene, anhydrous, 97%
Supelco
Electrolyte solution, nonaqueous, 2 M LiCl in ethanol
Supelco
o-Xylene, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
o-Xylene, suitable for HPLC, 98%
Sigma-Aldrich
o-Xylene, puriss. p.a., ≥99.0% (GC)
Sigma-Aldrich
o-Xylene, reagent grade, ≥98.0%